Trident Texofab responded to a BSE clarification request dated April 1, 2026, regarding significant share price movement.
The company confirmed all material information per SEBI LODR Regulation 30 and insider trading norms has been disclosed.
It attributed the share price movement solely to market conditions, over which it has no control or knowledge.